title: The modulatory role of melatonin on immune responsiveness.
abstract: Afterhe successful discovery of the melatonin molecule by Aaron B Lerner et al at Yale University in 1958, melatonin and the pineal gland, a tiny endocrine gland situated at the center of the human brain, have primarily been considered in terms of their effects on the endocrine and reproductive systems. During the last decade, a substantial body of research has defined melatonin as a remarkable molecule with pleiotropic effects on the immune system. Moreover, its synthesis cannot be considered as exclusively endocrine; key immunocompetent cells have the functional enzymatic machinery for melatonin synthesis, paving the wayfo r complex intracrine, autocrine and paracrine regulatory loops. The immunomodulatory role of melatonin, with regard to infection, inflammation and autoimmunity, is outlined here, and the evidence discussed in this review strengthens the notion that the nature of an immune response may be modified, and therefore therapeutically manipulated, by circadian effector signals.
authors.affiliation: Department of Medical Biochemistry and Molecular Biology, The University of Seville Medical School, Avda Sanchez Pizjuan 4, 41009 Seville, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Carrillo-Vico
authors.forename: Russel J
authors.initials: RJ
authors.lastname: Reiter
authors.forename: Patricia J
authors.initials: PJ
authors.lastname: Lardone
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Herrera
authors.forename: Rafael
authors.initials: R
authors.lastname: Fernández-Montesinos
authors.forename: Juan Miguel
authors.initials: JM
authors.lastname: Guerrero
authors.forename: David
authors.initials: D
authors.lastname: Pozo
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy; D001402:B-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis / Q000276:immunology; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000378:metabolism; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D008550:Melatonin / Q000096:biosynthesis / Q000276:immunology* / Q000627:therapeutic use; D010870:Pineal Gland / Q000378:metabolism*; D044094:Receptors, Melatonin / Q000378:metabolism; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D000949:Histocompatibility Antigens Class II; D044094:Receptors, Melatonin; D008550:Melatonin